SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,890 | -52.4% | 184,879 | +3.1% | 0.00% | – |
| Q2 2023 | $233,067 | -20.9% | 179,282 | +7.0% | 0.00% | – |
| Q1 2023 | $294,766 | -33.5% | 167,481 | +18.7% | 0.00% | – |
| Q4 2022 | $442,973 | -32.9% | 141,074 | +4.7% | 0.00% | – |
| Q3 2022 | $660,000 | +15.2% | 134,690 | -2.7% | 0.00% | – |
| Q2 2022 | $573,000 | -23.0% | 138,469 | +8.0% | 0.00% | – |
| Q1 2022 | $744,000 | +15.2% | 128,187 | +48.5% | 0.00% | – |
| Q4 2021 | $646,000 | -23.1% | 86,296 | -7.5% | 0.00% | – |
| Q3 2021 | $840,000 | -91.2% | 93,309 | -88.4% | 0.00% | -100.0% |
| Q2 2021 | $9,599,000 | +1.1% | 801,873 | +5.9% | 0.00% | -33.3% |
| Q1 2021 | $9,491,000 | -13.9% | 757,463 | +7.2% | 0.00% | 0.0% |
| Q4 2020 | $11,024,000 | +88.0% | 706,440 | +13.8% | 0.00% | +50.0% |
| Q3 2020 | $5,865,000 | +1025.7% | 620,656 | +966.7% | 0.00% | – |
| Q2 2020 | $521,000 | +27.4% | 58,182 | -9.3% | 0.00% | – |
| Q1 2020 | $409,000 | +94.8% | 64,165 | +155.2% | 0.00% | – |
| Q4 2019 | $210,000 | -13.2% | 25,146 | -6.2% | 0.00% | – |
| Q3 2019 | $242,000 | -19.3% | 26,794 | -3.8% | 0.00% | – |
| Q2 2019 | $300,000 | -96.5% | 27,838 | -96.9% | 0.00% | -100.0% |
| Q1 2019 | $8,548,000 | +19.2% | 896,067 | +43.5% | 0.00% | 0.0% |
| Q4 2018 | $7,169,000 | -13.6% | 624,477 | +27.6% | 0.00% | 0.0% |
| Q3 2018 | $8,295,000 | +2.2% | 489,353 | -14.4% | 0.00% | 0.0% |
| Q2 2018 | $8,116,000 | -57.3% | 571,512 | -42.9% | 0.00% | -57.1% |
| Q1 2018 | $19,015,000 | -15.7% | 1,000,763 | -27.3% | 0.01% | -12.5% |
| Q4 2017 | $22,567,000 | +9.1% | 1,376,028 | -0.2% | 0.01% | 0.0% |
| Q3 2017 | $20,689,000 | +4210.2% | 1,379,205 | +2430.3% | 0.01% | – |
| Q2 2017 | $480,000 | +67.8% | 54,507 | -0.8% | 0.00% | – |
| Q1 2017 | $286,000 | +214.3% | 54,963 | +85.0% | 0.00% | – |
| Q4 2016 | $91,000 | -32.1% | 29,702 | +2.9% | 0.00% | – |
| Q3 2016 | $134,000 | -1.5% | 28,873 | +22.8% | 0.00% | – |
| Q2 2016 | $136,000 | -4.9% | 23,513 | -0.4% | 0.00% | – |
| Q1 2016 | $143,000 | -99.0% | 23,600 | -98.3% | 0.00% | -100.0% |
| Q2 2015 | $15,047,000 | -8.2% | 1,356,752 | +29.8% | 0.01% | 0.0% |
| Q1 2015 | $16,384,000 | +726.6% | 1,044,894 | +701.9% | 0.01% | +500.0% |
| Q4 2014 | $1,982,000 | +68.7% | 130,310 | +19.7% | 0.00% | – |
| Q3 2014 | $1,175,000 | -92.2% | 108,890 | -89.0% | 0.00% | -100.0% |
| Q2 2014 | $15,099,000 | -15.5% | 988,834 | +0.1% | 0.01% | -14.3% |
| Q1 2014 | $17,865,000 | +668.4% | 988,093 | +490.4% | 0.01% | +600.0% |
| Q4 2013 | $2,325,000 | -68.1% | 167,366 | -75.9% | 0.00% | -66.7% |
| Q3 2013 | $7,297,000 | +104142.9% | 695,638 | +78237.6% | 0.00% | – |
| Q2 2013 | $7,000 | – | 888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |